USD
GBP
CNY
EUR
INR
JPY
MYR
ZAR
KRW
THB
U.S. Osteoporosis Therapeutics Markets
U.S. Osteoporosis Therapeutics Markets
RELEASE DATE
10-Jan-2005
10-Jan-2005
REGION
North America
North America
Research Code: F130-01-00-00-00
SKU: HC01412-NA-MR_05859
$2,450.00
Special Price $1,837.50 save 25 %
In stock
SKU
HC01412-NA-MR_05859
Description
This research service highlights the emerging opportunities in the U.S. osteoporosis therapeutics market and analyzes the current and future competitive landscape. Included in this research service are revenue forecasts, market shares, patient forecasts, market and technology trends, factors affecting market growth, major issues and challenges, pricing trends, and product analysis. The market is segmented by product class - bisphosphonates, SERMs, calcitonins and parathyroid hormones. Also included are individual revenue and patient forecasts for Fosamax, Actonel, Boniva, Zometa, Evista, lasofoxifene, basedoxifene, Forteo, Preos and Protos.
Table of Contents
Executive Summary
- Executive Summary
Overview
- Scope and Segmentation
- Research Methodology
- Introduction
- Market and Technology Trends
Market Dynamics
- Demand Analysis
- Patient Forecasts
- Revenue Forecasts
- Factors Affecting Market Growth
- Industry Issues and Challenges
Competitive Landscape
- Competitive Structure
- Pipeline Analysis
- Market Share Analysis
Frost & Sullivan Awards
- Product of the Year Award
- Industry Innovation and Advancement of the Year Award
- Product Innovation Award
- Technology Excellence Award
- Entrepreneurial Company of the Year
Overview
Market Forecasts and Trends
Competitive Analysis
Overview
Market Forecasts and Trends
Competitive Analysis
Overview
Market Forecasts and Trends
Competitive Analysis
Overview
Market Forecasts and Trends
Competitive Analysis
Decision Support Database
Popular Topics
This research service highlights the emerging opportunities in the U.S. osteoporosis therapeutics market and analyzes the current and future competitive landscape. Included in this research service are revenue forecasts, market shares, patient forecasts, market and technology trends, factors affecting market growth, major issues and challenges, pricing trends, and product analysis. The market is segmented by product class - bisphosphonates, SERMs, calcitonins and parathyroid hormones. Also included are individual revenue and patient forecasts for Fosamax, Actonel, Boniva, Zometa, Evista, lasofoxifene, basedoxifene, Forteo, Preos and Protos.
| No Index | Yes |
|---|---|
| Podcast | No |
| Industries | Healthcare |
| WIP Number | F130-01-00-00-00 |
| Is Prebook | No |